ID   175-62
AC   CVCL_W643
SY   MAb 175-62
DR   ATCC; PTA-1553
DR   Wikidata; Q54582352
RX   Patent=US8911735;
RX   PubMed=12869020;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1553.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06681; Human C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
RX   Patent=US8911735;
RA   Fung M.S.C., Sun C.R.-Y., Sun W.N.C.;
RT   "Complement inhibitors and uses thereof.";
RL   Patent number US6998468, 16-Dec-2014.
//
RX   PubMed=12869020; DOI=10.1046/j.1365-2249.2003.02213.x;
RA   Fung M.S.C., Lu M., Fure H., Sun W.N.C., Sun C.R.-Y., Shi N.Y., Dou Y.,
RA   Su J., Swanson X., Mollnes T.E.;
RT   "Pre-neutralization of C5a-mediated effects by the monoclonal antibody
RT   137-26 reacting with the C5a moiety of native C5 without preventing C5
RT   cleavage.";
RL   Clin. Exp. Immunol. 133:160-169(2003).
//